B. Riley analyst John Massocca raised the firm’s price target on Diversified Healthcare Trust (DHC) to $8.50 from $6.50 and keeps a Buy rating on the shares. The firm says the company’s 2026 outlook is an indicator of its “value growth potential.” It sees the stock’s discount to peers as “too severe.”

Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions

Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on DHC:

Disclaimer & DisclosureReport an Issue

Diversified Healthcare Trust Highlights Strong 2025 Performance Outlook

Is DHC a Buy, Before Earnings?

The Week That Was, The Week Ahead: Macro and Markets, Jan. 25

Diversified Healthcare Trust Gains Cash from AlerisLife Wind-Down

Diversified Healthcare Trust Reshapes Senior Living Operations